cerebral hemorrhage
Conditions
Interventions
control group:Placebo combined with basic Western medicine treatment
experimental group:Zhongfeng Xingnao Granules combined with Western medicine basic therapy
Sponsors
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 40 to 80 years; 2. Meet the diagnostic criteria for acute hemorrhagic stroke; 3. Acute cerebral hemorrhage onset time is less than 1 week; 4. NIHSS score >= 6 points; 5. Family or I sign a written informed consent form for participation in this trial. Who meet the above 5 items at the same time can be included in the study.
Exclusion criteria
Exclusion criteria: 1. The onset time was more than 1 week; 2. Cerebral hemorrhage was confirmed to be caused by brain tumors, brain trauma, hematological diseases (secondary to anticoagulant and thrombolytic therapy), vascular malformations or cerebral aneurysms; 3. Surgical treatment of patients; 4. Pregnant and lactating women; 5. Severe heart disease, heart dysfunction, liver dysfunction, renal dysfunction, respiratory failure, malignant tumor, gastrointestinal bleeding at the time of onset; 6. Psychiatric patients; 7. those who are participating in other clinical trials; 8. those who do not agree to participate in this trial. Those meeting any of the above shall be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mortality rate;Absorption rate of hematoma;National Institute of Health stroke scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| modified Rankin scale;Glasgow Score;Quality of life;the Barthelindex of ADL; | — |
Countries
China
Contacts
Public ContactXiaoyun Zhang
Outcome results
None listed